ABSTRACT
INTRODUCTION
Since the hepatocellular carcinoma (HCC) is cancer with the worst prognosis in terms of survival, early diagnosis and treatment are important for such patients. Serological marker analysis for high risk patients for HCC development can reduce HCC mortality and reduce treatment costs [1, 2] . HCC is a common in males than in females (2.4: 1). High frequency is recorded in East and South Asia, Central and West Africa and Polynesia [3] . Despite recent findings in the treatment of early and advanced hepatocellular carcinoma, the development of serum markers for the prognosis of therapeutic outcomes and treatment monitoring have not been investigated yet. Serological AFP has been very frequently used for better prognosis of disease and monitoring of therapeutic effect. Although serum AFP levels have been shown to increase in several cancers, this parameter is used as tumor marker for HCC only [4, 5] . AFP is used in diagnosis as an adequate marker due to its sensitivity and specificity for the diagnosis of HCC in patients with cirrhosis of the liver. The combination of this test with abdominal ultrasound test increases the sensitivity and specificity for HCC diagnosis [5] .
Recent studies emphasize that there is no optimal biomarker for HCC detection -it is suggested to use a combination of early detection biomarkers which include additional biomarkers such as DCP, GP73 and Lens culinaris agglutinin reactive AFP-L3 [4, 5] . Recent studies by ElGarem et al. suggest the use of tissue glypics 3 (GPC3), PAT10 (paternally expressed gene 10), serpine peptidase inhibitors (SERPINI1) and ubiquinol-cytochrome (QP-C)
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inhibitors that are also detected in the normal concentration of AFP [6] . Hepatitis B surface antigen (HBsAg) represents a significant risk for HCC development. Patients with positive hepatitis B core antibodies (anti-HBc) that are HBsAg-negative can develop HCC [7] .
The aim of the study is to investigate the possible correlation between AFP and specific biochemical in early HCC detection.
MATERIAL AND METHODS
This retrospective-prospective study includes all patients (31 males and 20 females) with a diagnosis of hepatocellular carcinoma that was treated at the Clinic for Gastroenterohepatology, Clinical Centre of the University of Sarajevo, in the period January 2010 -March 2013. Among patients, 35 had liver cirrhosis of viral C and 16 patients with B etiology that developed in liver cancer (hepatocellular carcinoma or HCC). The research was conducted at the Clinic for Gastroenteropathology of the Clinical Center of the Univesity of Sarajevo. Approval for research has been given by the Ethics Committee of the Clinical Center.
Biochemical and pathohistological analysis Following biochemical parameters were collected: bilirubin (total, direct and indirect), enzyme activity (aspartate aminotransferase -AST, alanine aminotransferase -ALT, gamma-glutamyltransferase -γGT and alkaline phosphatase -AP). Immunological tests for hepatitis markers included HBs Ag, anti-HBs, anti-HBc, anti-HCV and anti-HB while a serum alpha-fetoprotein -AFP was analyzed as a tumor marker. Biochemical parameters were analyzed using VITROS 5600 Integrated System analyzer (Ortho Clinical Diagnostics, USA) and Elisa method for detect hepatitis markers was used. For AFP analysis Hemiluminescent Micro-particle Immunoassay ARCHI-TECT AFP assay (CMIA, Ireland) was used. Imaging methods were used to detect morphological and pathohistological liver changes such as computerized tomography (CT) and ultrasonography (US).
Statistical analysis Data were analyzed using IBM SPSS Statistics ver. 20 (USA). Variance analysis (ANOVA) was used to test differences between groups. The non-parametric Spearman test was used for correlation analysis and for the normality test used the Kolmogorov-Smirnov test. Table 1 shows age and gender structure of HCC patients which are divided into four groups: young-aged (18-40 years), middle-aged (41-64), old-aged (65-74) and very old-aged (≥75 years). Male patients and (60.78%) and middle-aged group patients (41.17%) were the most represented among the whole HCC patients. Table 2 shows the distribution of tumor lesions in live lobes detected by EHO and CT. Patients were classified according to etiology in two groups: HCV and HBV. Liver cirrhosis has developed in hepatocellular carcinoma in both groups of patients. Among HCC patients 68.62% were HCV patients and the other 31.38% HBV patients.
RESULTS
These lesions mostly affected the right liver lobe (over 82%) in both groups. Only 6.25% of HCV patients had affected both lobes. The size of this lesion ranged from 3 to 20 cm. Splenomegaly with many local changes has also been reported in some patients.
The data analysis for biochemical parameters of HCC patients is presented in Table 3 . All analyzed parameters had increased values as well as a significant deviation of the normal distribution. The most noticeable variations were found for bilirubin (total, direct and indirect) and especially for AFP values. The values of biochemical parameters, as well as statistically significant differences between males and females (ANOVA) are presented in Table 4 . Males had higher values of bilirubin (total, direct and indirect) and AP compared Table 5 . shows the values of hepatitis markers for HCC patients. The most important diagnostic hepatitis marker present in HCC patients was HBs Ag with a frequency of 78% and anti-HBc (78.72%). All analyzed markers had high values, and the highest variations showed antiHBs Ag (0.3-4364 S/CO). Correlation between AFP and other parameters is shown in Table 6 . A positive correlation is established for all parameters, but only significant differences are found between AFP and γGT (r=0.372, p= 0.008).
DISCUSSION
HCC etiology varies across the globe, but so far in most studies where AFP was rated, viral hepatitis was the major cause of cirrhosis and HCC [4, 8, 9] . The prevalence of hepatitis B in our country is 1.5% compared to hepatitis C prevalence of 1% [10] . Our research has shown that the hepatitis B virus is the major cause of HCC which is consistent with the results of many epidemiological studies. Most of the HCC patients in our study were men. One reason is estrogen-mediated inhibition of IL-6 production from Kupfer's cells in women which reduces liver damage and prevents tumor spread. On the other hand, the effect of testosterone may increase the activation of androgen receptor in males inducing liver cell proliferation. In addition, the risk of HCC is higher in males due to higher exposure to liver-like carcinogens (such as smoking and alcohol) and higher rates of hepatitis by viral infections [11, 12] .
Hbs-Ag (surface antigen of hepatitis B virus, also known as Australian antigen) was detected in 78% HCC patients while anti-HCV antibodies were detected in 40.42% of patients. These results are similar to the results of Biliae-Komarca et al. [13] . Unlike our results Hernandez et al. [14] reported that previous HCV infection is the primary cause of HCC, which is consisted with the results of developed Western countries characterized by low prevalence of HBV compared to other countries such as Southeast Asia and Sub-Saharan Africa, where HBV infection is a major etiological factor [15] . On the other hand, antiHBc in our study was detected in all HBV patients, which could be a very important prognostic parameter for HCC development because of its highest frequency.
Biochemical markers that suggest a change in the liver metabolism such as bilirubin (direct, indirect, and total) were incresed. However bilirubin is not sufficient for diagnosis, but it is very diagnostically significant parameters in our research. High levels of enzymes activity can be the result of hepatic destruction leading to the release of the enzymes in serum. High ALT values are a liver destruction indicator [16] . According to Bashir et al. there are no significant changes for AP in HCV infection, but a significant increase in γGT in liver cirrhosis as well as in our research has been noted [17] .
Also, our results showed that there was no significant difference in the AFP values between males and females for the HCC patient although the average AFP values in males were slightly higher than females. These results are consist with the results of Tangkijvanich et al. and Peng et al. who also reported that average serological AFP levels in males with HCC were somewhat higher than females but this difference was not significant [18, 19] .
Our data indicate that the type of viral infection affects serum levels of AFP in HCC patients, which is not consistent with the results of previous research [20] . Namely, our research has shown that patients with HBVrelated HCC had significantly higher AFP values compared to HCV-related HCC patients. This result indicates the role of HBV not only in the etiology of hepatocellular carcinoma but also in the reactivation of genes encoding this fetal protein. High levels of serum AFP in HBV positive HCC patients were also demonstrated in a study Biochemical and serological parameters including AFP as tumor marker are a useful tool for the diagnosis of HCC in patients with cirrhosis of the liver. However, the senistivity and specificity of final diagnosis can be incresed using imaging methods. High AFP values in correlation with γGT values as well as serological parameters, especially HBs-Ag and anti-HBc, are a safe indicator of liver damage and very important as prognostic parameters in early detection of liver changes, HCC development and patient therapy.
CONCLUSIONS
In conclusion, a positive correlation was detected between concentration of AFP and other biochemical parameters. We estimated significant difference between concentration of AFP and γGT activity. High values and ratio between AFP and γGT are a powerful diagnostic marker to distinguish liver cirrhosis and hepatocellular carcinoma.
